Foresite Capital Management II, LLC's Net Worth
$0
Estimate Recalculated Sep 8, 2024 07:33PM EST
Who is Foresite Capital Management II, LLC?
Foresite Capital Management II, LLC does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include 10x Genomics, Inc., AERIE PHARMACEUTICALS INC, and Aimmune Therapeutics, Inc..
SEC CIK
Foresite Capital Management II, LLC's CIK is 0001594912
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
10x Genomics, Inc. (TXG) Snapshot price: $22.65
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +8.94% | 480.2K |
$80.13 | -$116,188,500.00 | 5.85M |
May 12 - May 13
| |||
Form 4
| +59.35% | 2M |
—
|
—
| 5.37M |
May 6
| |||
Form 4
| +14.67% | 392.26K |
—
|
—
| 3.07M |
Apr 22 - Apr 23
| |||
Form 4
| +13.29% | 387.81K |
—
|
—
| 3.3M |
Apr 13 - Apr 14
| |||
Form 4
| +1,157.66% | 2.17M |
—
|
—
| 2.36M |
Mar 24
| |||
Form 4
| +15.36% | 559K |
$59.00 | -$44,250,000.00 | 4.2M |
Mar 4 - Mar 18
| |||
Form 4
|
∞
| 187.5K |
$39.00 | $7,312,500.00 | 187.5K |
Sep 12 - Sep 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AERIE PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -18.10% | -1.00M |
$17.07 | -$17,070,000.00 | 4.52M |
Feb 27
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +1.94% | 115.9K |
$18.46 | $2,140,890.00 | 6.09M |
Sep 4 - Sep 5
| |||
Form 4
| +3.33% | 75K |
$21.00 | $1,574,741.00 | 2.33M |
Aug 30 - Sep 3
| |||
Form 4
| +2.09% | 46.15K |
$23.45 | $1,082,449.25 | 2.25M |
Aug 21 - Aug 23
| |||
Form 4
| +7.50% | 153.85K |
$23.88 | $3,673,288.98 | 2.2M |
Aug 16 - Aug 20
| |||
Form 4
| +19.13% | 539.55K |
$24.34 | $13,341,170.45 | 3.36M |
Aug 12 - Aug 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| -0.55% | -20.00K |
$55.95 | -$1,119,000.00 | 3.62M |
May 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4/A
| -1.48% | -50.00K |
$40.34 | -$2,016,995.00 | 3.32M |
Oct 6
| |||
Form 4
| -1.48% | -50.00K |
$40.34 | -$2,016,995.00 | 3.32M |
Oct 6
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +17.27% | 250K |
$17.50 | $4,375,000.00 | 1.7M |
Jul 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aimmune Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| -5.40% | -240.00K |
$15.23 | -$3,654,720.00 | 4.2M |
May 31
| |||
Form 4
| +7.73% | 25.48K |
$19.65 | $500,900.03 | 355.02K |
Aug 24
| |||
Form 4
|
∞
| 4.42M |
$16.12 | $5,349,198.76 | 4.42M |
Aug 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||